(Q44988720)

English

Phase I study of continuous-infusion soluble CD4 as a single agent and in combination with oral dideoxyinosine therapy in children with symptomatic human immunodeficiency virus infection

scientific article published on October 1, 1992

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Phase I study of continuous-infusion soluble CD4 as a single agent and in combination with oral dideoxyinosine therapy in children with symptomatic human immunodeficiency virus infection (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1357124

17 September 2022

1 reference

based on heuristic

inferred from title

author name string

R. N. Husson

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1357124

17 September 2022

Y. Chung

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1357124

17 September 2022

J. Mordenti

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1357124

17 September 2022

K. M. Butler

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1357124

17 September 2022

S. Chen

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1357124

17 September 2022

A. M. Duliege

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1357124

17 September 2022

P. Brouwers

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1357124

17 September 2022

P. Jarosinski

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1357124

17 September 2022

B. U. Mueller

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1357124

17 September 2022

A. Ammann

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1357124

17 September 2022

language of work or name

0 references

publication date

1 October 1992

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

The Journal of Pediatrics

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

121

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

627-633

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

The CD4 antigen: physiological ligand and HIV receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981161-8

7 January 2021

The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981161-8

7 January 2021

A soluble CD4 protein selectively inhibits HIV replication and syncytium formation

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981161-8

7 January 2021

HIV infection is blocked in vitro by recombinant soluble CD4.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981161-8

7 January 2021

A soluble form of CD4 (T4) protein inhibits AIDS virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981161-8

7 January 2021

Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981161-8

7 January 2021

Soluble CD4 molecules neutralize human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981161-8

7 January 2021

Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981161-8

7 January 2021

Synergistic inhibition of human immunodeficiency virus type 1 (HIV-1) replication in vitro by recombinant soluble CD4 and 3'-azido-3'-deoxythymidine

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981161-8

7 January 2021

Recombinant soluble CD4 therapy in patients with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. A phase I-II escalating dosage trial

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981161-8

7 January 2021

The safety and pharmacokinetics of recombinant soluble CD4 (rCD4) in subjects with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. A phase 1 study.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981161-8

7 January 2021

Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981161-8

7 January 2021

High-performance liquid chromatographic method for analysis of 2',3'-dideoxyinosine in human body fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981161-8

7 January 2021

Clinical pharmacology of 2',3'-dideoxyinosine in human immunodeficiency virus-infected children.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981161-8

7 January 2021

Dideoxycytidine alone and in an alternating schedule with zidovudine in children with symptomatic human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981161-8

7 January 2021

Bacterial infections in human immunodeficiency virus type 1-infected children: the impact of central venous catheters and antiretroviral agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981161-8

7 January 2021

Dideoxyinosine in Children with Symptomatic Human Immunodeficiency Virus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981161-8

7 January 2021

High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981161-8

7 January 2021

Envelope proteins from clinical isolates of human immunodeficiency virus type 1 that are refractory to neutralization by soluble CD4 possess high affinity for the CD4 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981161-8

7 January 2021

Resistance of primary isolates of human immunodeficiency virus type 1 to soluble CD4 is independent of CD4-rgp120 binding affinity

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981161-8

7 January 2021

Designing CD4 immunoadhesins for AIDS therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981161-8

7 January 2021

Complications of central venous catheters in pediatric patients with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981161-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0022-3476(05)81161-8

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44988720&oldid=1892555902"